Skip to main content
. 2022 Jun 7;2022(3):hoac024. doi: 10.1093/hropen/hoac024

Table II.

The baseline characteristics of all recurrent pregnancy loss patients.

Characteristics All RPL patients ≤500 μg/l 501–3000 μg/l >3000 µg/l P a
(N = 119) (N = 102) (N = 46)
Age, years, mean ( ± SD) 33.2 (±5.3) 33.4 (±5.3) 32.8 (±5.5) 33.6 (±5.1) 0.84
BMI, b kg/m2, median (P10/P90) 25.4 (20.0/34.5) 25.5 (19.5/34.0) 25.0 (20.0/35.0) 26.5 (20.5/33.5) 0.20
Maternal smoking, N (%) 35 (13.1) 16 (13.4) 13 (12.7) 6 (13.0) 1.0
No. of consecutive pregnancy losses, median, N (range) 3 (3–13) 3 (3–13) 3 (3–8) 4 (3–10) 0.87
pRPL, N (%) 144 (53.9) 65 (54.6) 59 (57.8) 20 (43.5) 0.26
sRPL, N (%) 123 (46.1) 54 (45.4) 43 (42.2) 26 (56.5)
Treatment after admission, N (%)
 IVIG 85 (31.8) 40 (33.6) 30 (29.4) 15 (32.6) 0.79
 ART 78 (29.2) 37 (31.1) 30 (29.4) 11 (23.9) 0.66

RPL, recurrent pregnancy loss; pRPL, primary RPL; sRPL, secondary RPL; IVIG, intravenous immunoglobulin; ART, IVF and ICSI; p-MBL, plasma mannose-binding lectin.

a

P-value for differences between the three RPL subgroups according to p-MBL level.

b

Two missing values.